Retraction notices

Effectiveness and safety of sorafenib for renal cell, hepatocellular and thyroid carcinoma: pooled analysis in patients with renal impairment

Type

Retraction

Notice date

9/16/2023 0:00

Journal

Cancer Chemotherapy and Pharmacology

Publisher

Springer

Notice DOI

10.1007/s00280-023-04587-8

Original paper DOI

10.1007/s00280-022-04428-0

Reasons

• Concerns/Issues about Data
• Error in Analyses
• Error in Methods
• Results Not Reproducible
• Unreliable Results and/or Conclusions

Matching venue names

Name match only, not an authoritative journal identifier.

• Cancer Chemotherapy and Pharmacology